ArticleBMC cancer2023

High expression of CDKN2A is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy.

Yuying Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.